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a b s t r a c t
Life under aerobic conditions has shaped peroxiredoxins (Prx) as ubiquitous thiol-dependent hydro-
peroxidases and redox sensors. Structural features that balance the catalytically active or inactive redox
states of Prx, and, therefore, their hydroperoxidase or sensor function, have so far been analyzed
predominantly for Prx1-type enzymes. Here we identify and characterize two modulatory residues of
the Prx5-type model enzyme PfAOP from the malaria parasite Plasmodium falciparum. Gain- and loss-of-
function mutants reveal a correlation between the enzyme parameters and the inactivation suscept-
ibility of PfAOP with the size of residue 109 and the presence or absence of a catalytically relevant but
nonessential cysteine residue. Based on our kinetic data and the crystal structure of PfAOPL109M, we
suggest a novel mechanism for balancing the hydroperoxidase activity and inactivation susceptibility of
Prx5-type enzymes. Our study provides unexpected insights into Prx structure–function relationships
and contributes to our understanding of what makes Prx good enzymes or redox sensors.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Peroxiredoxins (Prx) are among the most abundant proteins in a
cell and play central roles not only as detoxifying hydroperoxidases
but also as redox-regulated chaperones and redox sensors [1–6]. How
are these alternative functions balanced? Furthermore, which protein
properties determine whether a Prx maintains its enzymatic activity
or becomes inactivated? These questions have been adequately
addressed for the so-called Prx1-type enzymes with or without an
YF motif close to the C-terminus [1,7–15] but remain mostly unan-
swered for the other ﬁve Prx subfamilies.
The human malaria parasite Plasmodium falciparum has ﬁve
different parasite-encoded Prx [16–19] and imports a high-abundant
erythrocytic Prx that contributes to hydroperoxide removal [20]. One
of the parasite-encoded Prx, the so-called antioxidant protein PfAOP, is
a model enzyme for a special subclass of Prx with a high enzymatic
activity using glutaredoxin (Grx) and reduced glutathione (GSH) as
electron donors [21]. PfAOP has a prokaryotic ancestry and is dual
localized to the parasite cytosol and plastid most likely because of a
gene fusion event following a horizontal gene transfer [22]. Based on
its dimerization site and other structural features, PfAOP belongs to the
Prx5-type subfamily of Prx [23–25]. Rather little is known about the
physiological relevance and functions of this subfamily. Variants of
mammalian Prx5 are found in a number of tissues in mitochondria,
peroxisomes, the cytosol, and the nucleus and were reported to
prevent mitochondrial DNA damage and to modulate cell death
[25–29]. A prx5–grx hybrid gene from Haemophilus inﬂuenzae was
shown to be essential for stationary cultures under aerobic but not
anaerobic growth conditions [30]. Furthermore, the mechanistically
unusual Prx5-type enzyme Ahp1 from yeast was shown to form an
intermolecular disulﬁde bond with the transcription factor Cad1 and
to redox-regulate Cad1 in a hydroperoxide-dependent manner [31].
Structural features that balance the redox states and therefore the
hydroperoxidase and regulatory functions of Prx5-type enzymes are
so far unknown.
The active site of PfAOP contains the essential peroxidatic cysteine
residue Cys117, which reacts with the hydroperoxide substrate to a
sulfenic acid [21,23]. This rapid oxidative half-reaction has been
thoroughly analyzed for human Prx5 and requires a threonine and
arginine residue to stabilize the transition state [3,32,33]. Residues
Thr114 and Arg195 are conserved in PfAOP [23], whereas a second
arginine or a histidine residue, which were suggested to affect the
oxidative half-reaction in Prx1-type [34] and Prx6-type [35,36]
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enzymes, respectively, are absent. In addition, PfAOP has a second
cysteine residue (Cys143) with unknown function [21]. This cysteine is
found in a variety of Prx5-type homologues from bacteria, plants,
and animals including human [21,37–39] (Fig. 1A). Since Cys143 is
buried in the crystal structure of PfAOP [23], we were surprised to
detect its glutathionylation in vitro and in Escherichia coli [21].
SDS-PAGE redox mobility shift assays furthermore indicated a rever-
sible as well as time- and concentration-dependent hydroperoxide-
and GSH-dependent formation and reduction of an intramolecular
disulﬁde bond between Cys117 and Cys143 in vitro [21]. Although
Cys143 was shown to be nonessential for PfAOP catalysis, its replace-
ment with serine reduced the kcatapp value and affected the enzyme
kinetic patterns. This might be correlated with signiﬁcant structural
rearrangements that must be postulated to allow the formation of an
intermolecular or intramolecular disulﬁde bond [21], as the sulfur
atoms of Cys117 and Cys143 in the X-ray structure of PfAOP are about
7.8 Ǻ apart and are separated by the side chain of Leu109 at the
bottom of the active site pocket [23] (Fig. 1B). Interestingly, the side
chain of Leu109 adopts different conformations in subunits A and B of
the crystallized homodimer (Figs. 1C,D). We therefore hypothesized
that this residue might play a regulatory role as a gatekeeper that
controls the accessibility of Cys143 [21]. Here we characterized the
relevance of Leu109 and Cys143 for PfAOP catalysis and suggest a
novel mechanism for balancing the hydroperoxidase activity and
inactivation susceptibility of Prx with implications for redox
regulation.
Materials and methods
Site-directed mutagenesis, heterologous expression, and protein
puriﬁcation
Residue Leu109 of PfAOP was replaced by site-directed mutagen-
esis according to a previously described protocol using the plasmids
PFAOP/pQE30 and PFAOPC143S/pQE30 as templates [21]. The mutagen-
esis primers are listed in Supplementary Table 1. Correct sequences of
PFAOPL109A, PFAOPL109A/C143S, PFAOPL109V, PFAOPL109V/C143S, PFAOPL109M,
PFAOPL109M/C143S, PFAOPL109Q, and PFAOPL109Q/C143S were conﬁrmed by
sequencing both strands. Recombinant N-terminally MRGSH6GS-
tagged wild-type PfAOP and single point mutants as well as the
glutathione reductase PfGR and the mutant glutaredoxin PfGrxC32S/C88S
were expressed in Escherichia coli strain XL1-Blue and puriﬁed by
afﬁnity chromatography as previously described [21,40]. Please note
that the His-tag in PfAOP is far away from the active site as well as the
protein dimerization site [21] and therefore should not affect the
enzymatic properties. Because the yields of the double mutants
PfAOPL109A/C143S and PfAOPL109Q/C143S were rather low under standard
expression conditions, all double mutants and the control PfAOPC143S
were expressed overnight at 28 1C in the presence of 0.1 mM
isopropyl-β-D-1-thiogalactopyranoside. Protein concentrations of the
eluates were determined using the Bradford assay with bovine serum
albumin as a standard [41]. Average yields for all PfAOP mutants per
liter of E. coli culture were between 0.6 mmol (13 mg) for PfAOPL109Q
and 1.1 mmol (25 mg) for PfAOPL109V/C143S.
Steady-state kinetics
Standardized kinetic assays for the determination of the activities
of PfGR, PfGrxC32S/C88S, and PfAOP were carried out at 25 1C using a
thermostated Jasco V-650 UV-visual spectrophotometer as previously
described [21,40,42]. Apparent kcat and Km values (kcatapp and Kmapp) for
tert-butyl hydroperoxide (tBOOH) were determined for wild-type and
mutant PfAOP in a coupled assay containing 150 mM NADPH, 1 mM
GSH, 1 U/ml PfGR, 5 mM PfGrxC32S/C88S, and 10 to 100 mM tBOOH.
Activity measurements with 5 to 100 mM H2O2 were performed with
150 mMNADPH, 2 mM GSH, 1 U/ml PfGR, and 2 mM PfGrxC32S/C88S, and
the activity of a reference cuvette containing all assay components
except for PfAOP was subtracted. The assay concentration for wild-
type and single mutant PfAOP was 1.5 mM, except for PfAOPL109M (0.5
to 1 mM) and PfAOPL109Q (3 mM). Double mutants were assayed at an
enzyme concentration of up to 10 mM for PfAOPL109Q/C143S. Kinetic data
obtained from initial velocity measurements were analyzed as pre-
viously described [21].
Fig. 1. The second cysteine residue and a potential gatekeeper of PfAOP and Prx5 homologues. (A) Sequence alignment of Prx5 stretches comprising the peroxidatic cysteine
residue, which is labeled with a “p,“ and the second cysteine residue, which is found in many bacterial and eukaryotic homologues. The potential gatekeeper residue is
shaded in green. Pf, P. falciparum; Bq, Bartonella quintana (gi|49474601); No, Nitrosococcus oceani (gi|77164827); Pt, Populus tremula (PDB 1TP9); At, Arabidopsis thaliana (gi|
21593881); Dm, Drosophila melanogaster (gi|78706776); Hs, Homo sapiens (PDB 2VL2). (B) Structure of PfAOP chain A as ribbon diagram with the peroxidatic Cys117 at the
beginning of helix α2, Leu109 at the end of β-strand 3, and Cys143 in β-strand 4 highlighted. (C) View along the two cysteine residues of PfAOP toward the bottom of the
active site pocket. Only selected residues (see Ref. [21]) of the crystal structure PDB entry 1XIY [23] are shown for clarity. The entry side for the hydroperoxide substrate is
behind oxidized Cys117 and cannot be seen from the chosen perspective. Subunit A reveals a potential gate between both cysteines with the sulfur atom of Cys117 at the back
pointing toward the sulfur atom of Cys143 at the front. The side chain of the potential gatekeeper Leu109 is depicted in dark red and adopts a partially “open” conformation.
(D) Same view along the cysteine residues of subunit B with residue Leu109 adopting a rather “closed” conformation.
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Protein crystallization and structure determination
Freshly puriﬁed PfAOPL109M was desalted on a PD-10 column
with ice-cold buffer containing 30 mM Tris, 1 mM EDTA, HCl, pH
8.0, at 4 1C. The buffer was supplemented with 14.3 mM 2-
mercaptoethanol before use. PfAOPL109M was crystallized by sitting
drop vapor diffusion at 4 1C with a reservoir composition of 0.1 M
sodium citrate, pH 5.6, 13% w/v PEG 4000, and 18% v/v 2-propanol.
Crystallization drops contained 250 nl 15 mg/ml PfAOPL109M mixed
with 500 nl reservoir solution. Data were collected at ESRF
Grenoble beam line ID29 at 100 K, integrated using XDS [43],
and scaled with AIMLESS [44,45]. Phases were obtained by
molecular replacement using PHASER [46] with PDB entry 1XIY
[23] as search model. Model building was done with COOT [47].
The structure was reﬁned using PHENIX [48] without NCS
restraints (Supplementary Table 2). Structure ﬁgures were created
with PyMOL [49]. The atomic coordinates and structure factors
have been deposited in the Research Collaboratory for Structural
Bioinformatics Protein Data Bank under PDB code 4D73.
Results
Generation and puriﬁcation of mutants
Before we replaced the potential gatekeeper Leu109 by site-
directed mutagenesis, we performed an in silico analysis based on
the published structure of PfAOP in its sulfonic acid state [23].
Using the mutate tool of Swiss-Pdb viewer [50], we introduced
either shorter or longer uncharged amino acids at position 109 in
order to vary the diameter of the potential gate between Cys117
and Cys143. Please note that position 109 in the modeled struc-
tures allowed not only the accommodation of the shorter amino
acid residues valine or alanine but also of the longer amino acid
residues glutamine or methionine without steric hindrance. We
therefore replaced Leu109 of recombinant PfAOP and PfAOPC143S
by site-directed mutagenesis and puriﬁed the wild-type and
mutant enzymes PfAOPL109A,V,M,Q and PfAOPL109A,V,M,Q/C143S (sum-
marized as PfAOPL109X) by afﬁnity chromatography. All proteins
were stable and of high purity as revealed by SDS-PAGE
(Supplementary Fig. 1). However, the hydroperoxidase activity
decreased over time, resulting, for example, in a loss of approx.
50% activity of PfAOPL109M after 3 days of storage at 4 1C. All
subsequent experiments were therefore performed with freshly
puriﬁed enzyme.
Residue 109 and 143 both affect the hydroperoxidase kinetics
Wild-type enzyme and mutants of PfAOP were analyzed in an
established coupled enzymatic assay with tBOOH, GSH, and
PfGrxC32S/C88S as substrates (Fig. 2 and Supplementary Table 3).
The mutant of PfGrx was previously shown to be functional in the
assay and was used in order to exclude Grx-dependent side
reactions [21]. The activities of PfAOPL109A and PfAOPL109V, contain-
ing a shortened hydrophobic gatekeeper candidate, were signiﬁ-
cantly decreased, whereas the activity of PfAOPL109M, containing a
longer hydrophobic gatekeeper candidate, was three times higher
than the activity of the wild-type enzyme (Fig. 2A). The increased
activity was not due to a direct oxidation of NADPH by PfAOPL109M
as revealed by control experiments without PfGrxC32S/C88S or PfGR
(data not shown) in accordance with previous results for the wild-
type enzyme [21]. Hence, the hydroperoxidase activity of PfAOP
could be correlated with the length of residue 109 in descending
order (Met4Leu4Val4Ala). Replacement of Leu109 by a long
hydrophilic residue in PfAOPL109Q resulted in the lowest enzymatic
activity (Fig. 2A), suggesting that not only the length but also the
apolarity of the side chain is crucial.
In order to decipher a potential inﬂuence of Cys143 on the
altered activities, we then analyzed the same mutations for
PfAOPC143S (Fig. 2B). While the decreased activities for Ala109,
Val109, and Gln109 in PfAOPC143S were comparable to the Cys143-
containing mutants, the activating effect for Met109 was lost in
PfAOPL109M/C143S. The data in Figs. 2A and B therefore indicate a
Cys143-dependent and Cys143-independent inﬂuence of residue
109 on catalysis. This interpretation was supported by the kinetic
patterns (Supplementary Fig. 2) and parameters (Fig. 2C and
Supplementary Table 3): Linear regression analyses for PfAOPL109M
and the wild-type enzyme yielded rather parallel lines in Line-
weaver–Burk plots (Supplementary Fig. 2a), whereas all other
mutants, including PfAOPL109M/C143S and its control PfAOPC143S,
appeared to have a common intersection point (Supplementary
Figs. 2A,B). Thus, the mutation Met109 altered the correlation
between the microscopic rate constants of the enzymatic reaction
either in a comparable way to all the other gatekeeper mutants
when Cys143 was absent (Supplementary Fig. 2B) or in an
alternative way when Cys143 was present (Supplementary
Fig. 2A). As indicated by the parallel lines in the Lineweaver–Burk
plot, PfAOPL109M had a similar catalytic efﬁciency as the wild-type
enzyme because of a threefold increased Kmapp and kcatapp value. In
contrast, an increase of the Kmapp value of all other mutants was
coupled to a decrease of the kcatapp value (Fig. 2C and Supplementary
Table 3). In summary, the kinetic data reveal an important role of
Leu109 for PfAOP catalysis and support a functional coupling
between the active site and Cys143 that is mediated with the help
of the gatekeeper residue.
Residues 109 and 143 affect the susceptibility of the enzyme to
inactivation
Prx from different species are well known for their inactivation
during turnover [8,10,11,51]. When we monitored the initial
hydroperoxidase activities of the PfAOPL109X mutants and the
corresponding controls, we noted signiﬁcant differences with
regard to the time courses and inactivation kinetics (Fig. 3A). In
order to analyze the inactivation, we normalized the time courses
and compared the relative activities over the ﬁrst 80 s during
turnover. The activities of PfAOPL109V and wild-type PfAOP
decreased signiﬁcantly faster during the assay than the activity
of PfAOPL109M (Fig. 3B). Moreover, even though PfAOPL109Q had the
lowest overall activity of the PfAOPL109X mutants (Fig. 2C), the
replacement by glutamine resulted in the highest durability in the
assay (Fig. 3B). A decreased inactivation was also observed for the
long gatekeeper residues Met109 and Gln109 in the double
mutants lacking Cys143. However, the effects were less pro-
nounced because replacement of the second cysteine residue itself
appeared to increase the enzyme durability during turnover
(Fig. 3C). In summary, the presence of Cys143 could render PfAOP
more susceptible to tBOOH-dependent inactivation, and, regard-
less of the polarity and overall activity, long gatekeeper residues
stabilize PfAOP during catalysis.
Next, we tried to identify the inactivated enzyme species that
accumulates in the tBOOH peroxidase assay. We previously
detected the time- and concentration-dependent formation and
reduction of disulﬁde-bridged species in the absence of either the
oxidizing or the reducing substrate using redox mobility shift
assays [21]. Attempts to monitor a potential accumulation of these
oxidized PfAOP species in the course of the enzymatic assay failed
because the alkylation kinetics for unmodiﬁed cysteine residues
were much too slow to become competitive in the presence of all
substrates, which is a common methodological pitfall [6,52]. We
therefore analyzed the reaction of PfAOP with H2O2 as an
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Fig. 3. Inactivation of PfAOPL109X mutants by tBOOH and H2O2. (A) Time course measurements with 100 mM tBOOH as hydroperoxide substrate. (B) Normalized activities of
PfAOPL109X mutants with tBOOH in the presence of Cys143. The wild-type enzyme served as a control. For each time course measurement from panel (A), the absorbances at
100 and 180 s were set as the maximum (Absmax) and minimum (Absmin) absorbances, respectively. (C) Normalized activities of PfAOPL109X mutants lacking Cys143.
PfAOPC143S served as a control. Relative absorbances were normalized as in panel B. (D) Michaelis–Menten plot of the hydroperoxidase activities of wild-type PfAOP,
PfAOPL109A, and PfAOPL109M with H2O2. Initial reaction velocities were determined within 5 s after the addition of enzyme, revealing a concentration-dependent inactivation
of mutant and wild-type enzyme by H2O2. All data are the mean 7 SD of at least four replicate measurements of two independent enzyme puriﬁcations.
Fig. 2. Steady-state kinetics of PfAOPL109X mutants with tBOOH. (A) Michaelis–Menten plot of the hydroperoxidase activities of PfAOPL109X mutants in the presence of Cys143.
The wild-type enzyme served as a control. (B) Michaelis–Menten plot of the hydroperoxidase activities of PfAOPL109X mutants lacking Cys143. PfAOPC143S served as a control.
(C) Comparison of the kinetic parameters kcatapp and Kmapp of PfAOPL109X mutants and controls from panels A and B. Absolute values are given in Supplementary Table 3. All
values were determined with 1 mM GSH, 5 mM PfGrxC32S/C88S, and variable concentrations of tBOOH in the assay, and all data are the mean 7 SD of three to ﬁve replicate
measurements of at least two independent enzyme puriﬁcations.
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alternative substrate. However, competitive quenching experi-
ments with H2O2 and catalase [53] were also unsuccessful in
monitoring the accumulation of oxidized PfAOP because inactiva-
tion by H2O2 was even far more potent than inactivation by tBOOH
as revealed by concentration–activity plots (Fig. 3D). It is interest-
ing to note that neither wild-type nor mutant PfAOP showed
apparent Michaelis–Menten kinetics with H2O2 as a substrate.
Instead, all enzymes were rapidly inactivated in a concentration-
dependent manner (Fig. 3D). An initial increase of the peroxidase
activity was only observed for PfAOPL109M at very low H2O2
concentrations, and PfAOPL109M was also the only enzyme with a
decreased susceptibility to inactivation and a signiﬁcant residual
activity at 100 mM H2O2. In contrast, PfAOPL109A was even more
efﬁciently inactivated than the wild-type enzyme. In summary,
H2O2 is not only a substrate but also a potent inhibitor of PfAOP
that leads to enzyme inactivation. The susceptibility to inactiva-
tion depends on residue 109 and is partially compensated in
PfAOPL109M.
Crystal structure of PfAOPL109M
In order to gain a deeper understanding of the unexpected
durability of PfAOPL109M and its increased kcatapp value, we crystallized
the mutant protein and solved its structure by molecular replacement
at 1.8 Å resolution (Supplementary Table 2) (PDB entry 4D73). The
overall structure was very similar to wild-type PfAOP (PDB entry 1XIY
[23]) with rmsd values of 0.26 and 0.22 Å for corresponding Calpha
atoms of chains A and B, respectively. As expected from modeling, in
subunit A the active center is in a closed state and Met109 is located
between Cys143 and “overoxidized” Cys117 (Fig. 4). Met109 adopts a
frequently observed side chain conformation [54] and is in close
contact with the side chain of Cys143, which was built with two
alternative side chain conformations due to the observed, broadened
electron density. Compared to the wild-type structure, the side chain
of Cys143 is rotated away from Cys117 (Fig. 4, left panels). In contrast
to subunit A, the peroxidatic Cys117 and the adjacent residues 115 to
119 of PfAOPL109M are disordered in subunit B, and the side chain of
Met109 is not in contact with Cys143 (Fig. 4, right panels). The other
residues in the vicinity of position 109 show very similar side chain
conformations in both subunits of the wild-type and mutant structure
(Supplementary Fig. 3). Please note that local unfolding of the active
site is in general crucial for Prx catalysis because it allows the attack
either of a resolving cysteine residue or of the reducing substrate, as
previously demonstrated for a number of Prx isoforms [3,9,12–
14,24,53,55–57]. Moreover, the different conformations of active sites
A and B observed in PfAOPL109M are in accordance with the previously
suggested negative subunit cooperativity for PfAOP [21].
PfAOPL109M has a very low Km
app value for GSH
GSH is a true substrate of PfAOP because Cys143 is nonessential for
catalysis and PfGrxC32S/C88S provides only one cysteine residue per
catalytic cycle and therefore cannot regenerate a thiol from a sulfenic
acid [21]. When we compared the activities of PfAOPL109M, PfAOPL109A,
and wild-type enzyme at variable GSH concentrations, all proteins had
biphasic kinetics as revealed by hyperbolic and linear regression
analysis (Fig. 5A,B) in accordance with previous observations for
PfAOP and PfAOPC143S [21]. However, PfAOPL109M was saturated at
much lower GSH concentrations with approx. 20- and 10-fold lower
Km1
app and Km2app values as compared with wild-type enzyme (Figs. 5B,C
and Supplementary Table 4). Hence, the mutation Met109 drastically
improved the apparent afﬁnity of oxidized PfAOP toward GSH,
whereas the kcat1app and kcat2app values at variable GSH concentrations
were only increased by approx. 40 and 20% under the chosen assay
conditions. The effect of Met109 on the reductive half-reaction was
speciﬁc for GSH, since PfAOPL109M and wild-type enzyme had similar
Km
app values for PfGrxC32S/C88S (Fig. 6 and Supplementary Table 5), even
though the kcatapp value of PfAOPL109M at variable Grx concentrations
was about 2.3 times higher as compared with wild-type enzyme. In
summary, PfAOPL109M has a much higher apparent afﬁnity for GSH but
not for Grx as compared to wild-type enzyme.
Discussion
How do residue 109 and Cys143 alter PfAOP catalysis, and how can
we explain the signiﬁcant gain of function for PfAOPL109M? During
Fig. 4. Comparison of the X-ray structures of PfAOPL109M and wild-type PfAOP. Chains A and B are shown on the left and right side, respectively. Residues 115–119 including
Cys117 of PfAOPL109M are disordered in chain B and cannot be seen. Upper panels: electron density map at 1.5 σ contour level of PfAOPL109M with 2Fobs–Fcalc. Lower left panel:
superposition of chain A of PfAOPL109M (light blue) and wild-type PfAOP (green) with side chains shown for residues Leu/Met109, Cys117, and Cys143. Lower right panel:
superposition of chain B of PfAOPL109M (blue) and wild-type PfAOP (dark green).
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turnover Prx adopt a variety of redox states such as E-SH, E-SOH, and
E-SSR (Fig. 7A). Moreover, E-SH and E-SOH exist in alternative
conformations with a folded or locally unfolded helix α2 (E-SHfo, E-
SOHfo, E-SOHlu, and E-SHlu) [3,10,13]. The peroxidatic cysteine residue
is highly reactive and rapidly forms a sulfenic acid [15,33], presumably
as soon as the hydroperoxide substrate adopts a correct orientation.
Hence, the regeneration of the reduced enzyme, including conforma-
tional changes and the formation of E-SSR and E-SHlu (Fig. 7A), is
probably rate limiting for many Prx [15,57,58]. Secondary plots from
previous kinetic measurements with GSH revealed that the “true“ kcat
of PfAOP tends to be inﬁnite [21]. Thus, it is probably impossible to
saturate the enzyme–substrate complex between PfAOP and GSH at
high tBOOH and PfGrx concentrations. In other words, binding and
deprotonation of GSH and/or the adoption of a correct orientation
between the oxidized enzyme and GSH might occur at a slower rate
than disulﬁde bond formation and could be the rate-limiting step
[57–59]. Our previous studies did not reveal whether GSH attacks E-
SOH or a mixed disulﬁde between PfAOP and PfGrx [21]. Although we
do not rule out the latter pathway, the data for PfAOPL109M rather
support a model with GSH as the ﬁrst reductant (Fig. 7B). A
comparison of the crystal structures of wild-type PfAOP and
PfAOPL109M suggests that the replacement of Leu with Met at position
109 alters the balance between the fully folded and the locally
unfolded conformation and has a destabilizing effect on the fully
folded conformation, which results in a disordered active site in
subunit B of PfAOPL109M. Hence, Met109 may alter the ratio of the
microscopic rate constants k3 and k–3 and accelerate local unfolding of
helix α2. As a result, the steady-state concentration of E-SOHlu would
increase (which could slow down the inactivation of PfAOP as outlined
below). In accordance with an increased E-SOHlu concentration, the
drastically lowered Kmapp of PfAOPL109M for GSH might reﬂect more
frequent successful encounters between the GSH and the enzyme. The
unchanged Kmapp of PfAOPL109M for PfGrxC32S/C88S also ﬁts into this
mechanistic model because E-SSG is trapped in the locally unfolded
state and cannot isomerize to the folded state. Hence, binding of
PfGrxC32S/C88S on the protein surface does not depend on k3/k–3 and
the gatekeeper mutation. If the replacement of Leu109 with methio-
nine also affects k8/k–8, the increased Kmapp of PfAOPL109M for tBOOH
might analogously reﬂect a decreased steady-state concentration of E-
SHfo that results in less frequent successful encounters between
tBOOH and the enzyme. In addition, residue 109 at the bottom of
the active site pocket should also affect the pKa value and orientation
of the peroxidatic cysteine in its folded conformation and therefore
directly alter the reactivity with the peroxide substrate. A mechanistic
coupling between the peroxidatic cysteine and Cys143 in accordance
with our gatekeeper hypothesis is supported by two observations.
Fig. 5. Steady-state kinetics of PfAOPL109X mutants with GSH. (A) Michaelis–Menten plot showing the biphasic GSH-dependent hydroperoxidase activities of PfAOPL109M,
PfAOPL109A, and wild-type PfAOP with tBOOH. Closed and dashed lines indicate the hyperbolic ﬁts for the values at high (closed symbols) and low (open symbols) GSH
concentrations, respectively. (B) Hanes plot with -Kmapp values for GSH as x-intercepts. Closed and dashed lines indicate the linear ﬁts for the data at high (closed symbols) and
low (open symbols) GSH concentrations, respectively. (C) Comparison of the kinetic parameters kcatapp and Kmapp (see also Supplementary Table 4). All values were determined
with 75 mM tBOOH, 2 mM PfGrxC32S/C88S, and variable concentrations of GSH in the assay, and all data are the mean 7 SD of three to six replicate measurements of at least
three independent enzyme puriﬁcations.
Fig. 6. Steady-state kinetics of PfAOPL109M and wild-type enzyme with PfGrxC32S/C88S. (A) Michaelis–Menten plot of the Grx-dependent hydroperoxidase activities with
tBOOH. (B) Hanes plot with -Kmapp values for Grx as x-intercepts. (C) Comparison of the kinetic parameters kcatapp and Kmapp (see also Supplementary Table 5). All values were
determined with 75 mM tBOOH, 1 mM GSH, and variable concentrations of PfGrxC32S/C88S in the assay, and all data are the mean 7 SD of three to six replicate measurements
of at least three independent enzyme puriﬁcations.
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First, the gain of function for Met109 requires the presence of Cys143
and, second, detrimental effects of the gatekeeper mutations are
increased by the replacement of Cys143. One might speculate that
the sulfur atom of Met109 results in an altered redox mechanism;
however, the electron densities in the crystal structure and general
chemical considerations rather speak against an involvement of a
methionine sulfoxide, radical or homocysteine species. In summary,
the combined inﬂuence of Cys143 and residue 109 on catalysis could
be explained by a direct effect on the reactivity of the peroxidatic
cysteine residue as well as indirect effects on the reaction with GSH
because of altered conformational dynamics of helix α2.
If a single point mutation leads to a 20-fold decrease of the Kmapp
value for the potentially rate-limiting substrate interaction and a
threefold increase of the kcatapp value, why is such a mutant not selected
in vivo (i.e., in apicomplexan parasites or other organism with similar
Prx5 homologues)? One of several plausible answers to this question
could be that the optimization of the peroxidase function might result
in the loss of another function. Prx isoforms have been suggested, and
in several cases shown, to act not only as peroxidases but also as redox
sensors [2,4–6,10,60,61]. The molecular basis of what makes Prx good
redox sensors is not fully understood, and there are probably alter-
native mechanisms to balance alternative functions, depending on the
Prx subfamily or individual enzyme. For several members of the Prx1-
type subfamily the E-SOHfo species is stabilized by an YF motif close to
the C-terminus. A delayed unfolding of helix α2 makes these enzymes
more susceptible to the reaction with another peroxide substrate. The
resulting overoxidized Prx is inactive and has altered protein-protein
interactions [3,6,10,51,62]. Alternatively, the formation of particular E-
SSR species was suggested as a common principle for redox sensing
[4]. Examples for such species are the mixed disulﬁdes between
mammalian Prx1/2 and Ask1 [63], yeast Ahp1 and Cad1 [31], as well
as yeast Prx1 and Trx3 [64]. Whether PfAOP plays a role as a redox
sensor is unknown; however, the efﬁcient inactivation by H2O2 could
point to this direction. As far as E-SSR formation is concerned, we
previously detected a variety of PfAOP species in vitro that might have
suitable sensor properties [21]. The present study reveals that Cys143
and short gatekeeper residues make PfAOP more susceptible to
turnover-dependent inactivation, whereas long gatekeeper residues
or the absence of Cys143 slow down inactivation. So far we could not
specify the inactivated PfAOP species that accumulates in the assay
(despite a variety of experimental approaches). The two most likely
and nonexclusive possibilities for inactivated PfAOP are (i) E-SSR
species and/or (ii) overoxidized species (Fig. 8). (i) As shown for
PfAOPL109M, the shielding of the thiol group of Cys143 correlates with
the length of the gatekeeper. A decreased shielding might facilitate the
formation of the previously detected Cys143 disulﬁdes [21] and could
Fig. 7. Mechanistic model for PfAOP catalysis. (A) General model for Prx catalysis. (B) Potential effects of residue 109 and the second cysteine residue on PfAOPL109M catalysis.
The active site pocket where hydroperoxide reduction takes place is indicated by a dashed line. Crucial protonation and deprotonation steps are omitted for simplicity.
Fig. 8. Mechanistic model for PfAOP inactivation with implications for potential redox sensing. Altered conformational dynamics (indicated by red arrows) and gatekeeper-
dependent shielding of the second cysteine residue could affect the formation of the previously detected E-SSR species [21] or the formation of the sulﬁnic and sulfonic acid
species as detected in the crystal structure (Fig. 4) [23] and by mass spectrometry [21]. (A) Short gatekeeper mutants (Sg) have a delayed unfolding of helix α2 and a less
shielded second cysteine residue. As a result, turnover decreases, and the enzyme is more susceptible to inactivation. (B) Long gatekeeper constructs (Lg) have a promoted
unfolding of helix α2 and a highly shielded second cysteine. As a result, turnover increases, and the enzyme has an increased durability. The altered ratio between active and
inactive enzyme species in panels A and B is indicated by blue arrows.
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therefore explain some of the altered inactivation properties. (ii) Since
PfAOP is structurally prone to overoxidation [23], different inactivation
kinetics probably indicate an altered accumulation of the sulﬁnic or
sulfonic acid states during turnover. As outlined above, the analyzed
mutations presumably affect the unfolding dynamics of helix α2. Thus,
the durability of the long gatekeeper mutants could be analogous to
the durability of Prx1-type isoforms without the YF motif, and the
susceptibility of the short gatekeeper mutants to inactivation could be
caused by a delayed unfolding of helix α2 analogous to Prx1-type
isoforms with a YF motif [3,10,51]. Regardless of the chemical nature
of inactive PfAOP, it remains to be shown whether the modulatory
effects of Cys143 and the gatekeeper reﬂect a common balancing
mechanism for catalysis and inactivation. Based on the decreased
activity and slightly increased inactivation of the Val109 mutants, Prx5
homologues from plants, Drosophila, and human might be more
susceptible to inactivation than bacterial Prx5 homologues, because
the former enzymes have a valine instead of a leucine residue at the
gatekeeper position (Fig. 1) [21]. If this is the case, the balancing
mechanism would be the result of a convergent molecular evolution
for Prx5-type and Prx1-type homologues. In summary, increased
shielding of residue Cys143 by the gatekeeper and an accelerated
unfolding of helix α2 are two nonexclusive models to explain the
insensitivity of PfAOPL109M toward inactivation. A gain of functionwith
regard to the hydroperoxidase activity and enzyme durability might
be coupled to a loss of function for redox sensing in vivo.
In conclusion, our mutational analyses unraveled a modulatory
effect of Cys143 and residue 109 on PfAOP catalysis and inactivation.
Both residues directly alter the reactivity of the peroxidatic cysteine
toward the hydroperoxide substrate in the folded enzyme conforma-
tion. In addition, both residues appear to affect the local unfolding of
helix α2 which inversely alters the susceptibility to enzyme inactiva-
tion and the reactivity toward GSH as the ﬁrst reductant. The more
robust and active enzyme PfAOPL109M might be interesting for the
design of recombinant peroxidases. Furthermore, its gain of function
in vitromight be detrimental in vivo because of a loss of function with
regard to redox sensing. Future analysis will have to reveal whether
the second cysteine residue and the Prx5-type subfamily of Prx are
redox-regulated in vivo. The gatekeeper mutants described here might
provide a useful tool for addressing this subject.
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